Novartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's Xolair in a Phase II clinical trial against urticaria, also known as hives.
Novartis goes after Roche asthma medicine Xolair with new drug
![Novartis goes after Roche asthma medicine Xolair with new drug]()
Reviewed by jenisht
on
December 04, 2018
Rating:
No comments: